Article
The host-pathogen interaction of human cyclophilin A and HIV-1 Vpr requires specific N-terminal and novel C-terminal domains.
BMC structural biology - 20 Dec 2011
Solbak Sara M Ø, Wray Victor, Horvli Ole, Raae Arnt J, Flydal Marte I, Henklein Petra, Henklein Peter, Nimtz Manfred, Schubert Ulrich, Fossen Torgils
Abstract excerpt
BACKGROUND: Cyclophilin A (CypA) represents a potential key molecule in future antiretroviral therapy since inhibition of CypA suppresses human immunodeficiency virus type 1 (HIV-1) replication. CypA interacts with the virus proteins Capsid (CA) and Vpr, however, the mechanism through which CypA influences HIV-1 infectivity still remains unclear. RESULTS: Here the interaction of full-length HIV-1 Vpr with the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
